Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Novel Antibody-Antigen Based Impedimetric Immunosensor for Low Level Detection of Her2 in Serum Samples of Breast Cancer Patients Via Modification of a Gold Nanoparticles Decorated Multiwall Carbon Nanotube-Ionic Liquid Electrode Publisher Pubmed



Arkan E1 ; Saber R2, 3 ; Karimi Z4 ; Shamsipur M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Medical Nanotechnology, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Research Center for Science and Technology in Medicine, Imam Khomeini Hospital, Tehran, Iran
  4. 4. Department of Chemistry, Payame Noor University, P.O. Box 19395-3697, Tehran, Iran
  5. 5. Department of Chemistry, Razi University, Kermanshah, Iran

Source: Analytica Chimica Acta Published:2015


Abstract

A highly sensitive impedimetric immunosensor based on a gold nanoparticles/multiwall carbon nanotube-ionic liquid electrode (AuNPs/MW-CILE) was developed for the determination of human epidermal growth factor receptor 2 (HER2). Gold nanoparticles were used to enhance the extent of immobilization and to retain the immunoactivity of the antibody Herceptin on the electrode. Cyclic voltammetry and electrochemical impedance spectroscopy were employed for characterization of various layers coated onto the AuNPs/MW-CILE. The impedance measurements at different steps were based on the charge transfer kinetics of the [Fe(CN)6]3-/4- redox pair. The immobilization of antibody and the corresponding antigen-antibody interaction at the electrode surface altered the interfacial electron transfer. The interactions of antibody with various concentrations of antigen were also monitored via the change of impedance response. The results showed that the charge transfer resistance increases linearly with increasing concentrations of HER2 antigen. The linear range and limit of detection were found as 10-110ngmL-1 and 7.4ngmL-1, respectively. The sensitivity and specificity of the immunosensor were validated. The results showed that the prepared immunosensor is a useful tool for screening of trace amounts of HER2 in serum samples of breast cancer patients. © 2015 Elsevier B.V.